Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous cord blood for children with autism spectrum disorder
MOH_2019-08-03_007326Phase 2Not yet recruiting
- Sponsor
- עמר בר יוסף
- Start
- Jun 2019
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Autism Spectrum Disorder (ASD) comparing Autologous cord blood first with Placebo first (2 arms). Planned start Jun 2019; status: not yet recruiting.
02
Drugs
autologous umbilical cord blood
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on MOH_2019-08-03_007326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2019-08-03_007326.